[Molecular pathogenesis and therapeutic targets of lysosomal diseases]

Seikagaku. 2007 Jul;79(7):678-82.

[Article in Japanese]

Authors

Daisuke Tsuji¹, Kohji Itoh

Affiliation

¹ Department of Medicinal Biotechnology, Institute of Health Biosciences, The University of Tokushima, 1-78 Sho-machi, Tokushima 770-8505, Japan.

PMID: 17763701

No abstract available

Publication types

Review

MeSH terms

1-Deoxynojirimycin / analogs & derivatives
1-Deoxynojirimycin / therapeutic use
Animals
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Aspirin / therapeutic use
Bone Marrow Transplantation
Disease Models, Animal
G(M2) Activator Protein / genetics
Genetic Therapy
Humans
Lysosomal Storage Diseases, Nervous System / genetics*
Lysosomal Storage Diseases, Nervous System / therapy*
Mutation
beta-N-Acetylhexosaminidases / genetics

Substances

Anti-Inflammatory Agents, Non-Steroidal
G(M2) Activator Protein
1-Deoxynojirimycin
miglustat
beta-N-Acetylhexosaminidases
Aspirin